Home  /  Resource Library  /  Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naive Patients: An Italian Multicenter Retrospective Observational Real-Life Experience

Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naive Patients: An Italian Multicenter Retrospective Observational Real-Life Experience

Real world study investigated acalabrutinib for treatment of CLL.